Ownership history in Euclidean Capital LLC · 21 quarters on record
This page tracks every 13F SEC filing in which Euclidean Capital LLC reported a position in FOGHORN THERAPEUTICS INC (FHTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 1,573,761 | — | 0% | 2.30% | $8.5M | $5.40 |
| 2025 Q3 | UNCHANGED | 1,573,761 | — | 0% | 3.23% | $7.7M | $4.89 |
| 2025 Q2 | UNCHANGED | 1,573,761 | — | 0% | 2.42% | $7.4M | $4.70 |
| 2025 Q1 | UNCHANGED | 1,573,761 | — | 0% | 2.16% | $5.74B | $3.65 |
| 2024 Q4 | UNCHANGED | 1,573,761 | — | 0% | 1.01% | $7.4M | $4.72 |
| 2024 Q3 | UNCHANGED | 1,573,761 | — | 0% | 1.62% | $14.7M | $9.31 |
| 2024 Q2 | UNCHANGED | 1,573,761 | — | 0% | 1.14% | $9.0M | $5.75 |
| 2024 Q1 | UNCHANGED | 1,573,761 | — | 0% | 1.35% | $10.6M | $6.71 |
| 2023 Q4 | UNCHANGED | 1,573,761 | — | 0% | 1.14% | $10.2M | $6.45 |
| 2023 Q3 | UNCHANGED | 1,573,761 | — | 0% | 1.72% | $7.9M | $5.00 |
As of 2025 Q4 — sorted by position size